Go or no go? The year ends with Covid-19 vaccine approvals in sight

After almost a year grappling with the coronavirus pandemic the most important job for US regulators next month will be reviewing the first Covid-19 vaccines. Biontech and Pfizer's project will be discussed at a panel on December 10, and while a date has yet to be set officially for Moderna to present its candidate a December 17 adcom has been rumoured.